2025 · 1st Quarter (Jan 1 - Mar 31)

EXELIXIS, INC.

Filed by ARNOLD & PORTER KAYE SCHOLER LLP.

Open official filing

Source-reported fields

Filing overview

Type: 1st Quarter - Report
Posted: Apr 18, 2025
Income: $60,000.00
Expenses: Not reported
Registrant: ARNOLD & PORTER KAYE SCHOLER LLP
Client: EXELIXIS, INC.
Filing UUID: 2f4b60f2-4ecc-4419-847f-662cf93299e5
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

Issues related to access, coverage, and payment for cancer drugs. Issues regarding the Inflation Reduction Act (Pub. L. No. 117-169), including implementation. Issues related to the Small Biotech Innovation Act (S. 5029, 118th Congress).

Literal federal measure citations: S. 5029

HCR · Health Issues

Issues related to access, coverage, and payment for cancer drugs. Issues regarding the 340B program. Issues related to biopharmaceutical intellectual property and patent matters.

TAX · Taxation/Internal Revenue Code

Issues related to research and development (R&D) tax credits.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.